Cardiology

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

AV nodal reentrant tachycardia: Diagnosis and Treatment

Acute Coronary Syndromes Management/CAD Management: Post-Discharge Considerations

Acute Coronary Syndromes Management: In-Hospital Treatment Considerations

Acute Severe Aortic Regurgitation

Aldosterone Receptor Antagonists

Anemia

Anemia

Angiotensin Receptor Blockers

Angiotensin-Converting Enzyme Inhibitors

Anticoagulant Therapy

Anticoagulation for Stroke Prevention in Atrial Fibrillation/flutter

Antiplatelet Therapy: Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Therapy: Thromboxane Antagonists

Antiplatelet Therapy: Adenosine Diphosphate Receptor Antagonists

Aortic Aneurysm Intervention

Aortic Stenosis

Aortic Valve Intervention

Assessing Prognosis Using Risk Scores

Asymptomatic CAD & Silent Ischemia: Roles of Stress Testing, Myocardial Imaging, Optimal Medical Therapy, and Myocardial Revascularization

Atrial Fibrillation/Atrial flutter: Pharmacologic and Catheter Ablation to Maintain Sinus Rhythm

Atrial Tachycardia: Diagnosis and Treatment

Atrial fibrillation: Rate Control: Options, Advantages, Disadvantages

Beta-Blockers

Beta-Blockers, Calcium Channel Blockers, Nitrates in CAD Management

Bifurcation Lesions

Biomarkers to Diagnose and Determine Risk

Brugada Syndrome

CABG Surgery: Acute and Long-Term Outcomes

CAD and Chronic Kidney Disease

CAD and Noncardiac Surgery

CAD and the Elderly: Diagnostic and Therapeutic Considerations

Cardiac Implantable Electrical Devices: Management of Complications; Indications for Lead Extraction

Cardiac Resynchronization Therapy

Cardiopulmonary Exercise Testing

Cardiopulmonary Exercise Testing

Cardiorenal syndrome in heart failure patients

Carotid Intervention

Causes of Heart Failure

Chemotherapy Induced Cardiomyopathy

Chest Pain Without Epicardial Stenosis – Diagnosis and Treatment of Spasm and Microvascular Angina

Chest Pain in the Emergency Department: Differential Diagnosis

Chronic Total Occlusions

Congenital Intervention – Angioplasty (Pulmonary Arteries and Veins)

Congenital Intervention – Atrial Septal

Congenital Intervention – PDA, Coarctation, Pulmonary AVM, and Coronary Fistulae

Congenital Intervention – Pulmonary Valve Replacement

Congenital Intervention – Systemic Venous

Congenital Intervention – Vascular Access

Defining the Presence of Coronary Artery Disease in the Heart Failure Patient

Depression

Depression

Determining Quality of Life

Devices

Diagnosing and Classifying Pulmonary Hypertension

Diagnosis and Management of Chronic Aortic Regurgitation

Diagnosis and Management of Mitral Stenosis

Diagnosis of Heart Failure by History and Physical Examination

Diagnostic Approach to Defining CAD in Women

Differential Diagnosis of Wide QRS Complex Tachycardias

Digoxin

Disease Management Programs: Patient Selection and Outcomes

Diuretic Agents

Drugs Used for Immunosuppression Post-transplant

Embolic Protection Devices

End of Life Care

Endomyocardial Biopsy

Evaluation and Management of Syncope

Evaluation and Treatment of AV Block and Intraventricular Conduction Disturbances

Evaluation and Treatment of Sick Sinus Syndrome

Evaluation of the Patient with Decompensated Heart Failure

Exercise Training and Heart Failure

Exercise and Fitness in the Prevention and Treatment of CAD

Familial Dilated Cardiomyopathy

Femoral Arterial Access and Complications

Fractional Flow Reserve

How Do We Best Achieve Smoking Cessation, Ideal Body Weight, and Weight Loss as Modifiable Risk Factors

How to Manage the Complex Patient with Mixed Dyslipidemia (Elevated non-HDL-C; Low HDL-C; Elevated TG: Role of Niacin, Fibrins, Fibrates, etc.)

Hypertrophic Cardiomyopathy Intervention

Hypertrophic Cardiomyopathy: Management and Genetic Counseling

ICD Shocks: Evaluation and Management

Implantable cardioverter-defibrillators: Primary and Secondary Prevention of Sudden Cardiac Death

Inflammation and CAD: Use of hs-C-Reactive Protein as a Diagnostic and Prognostic Tool

Interventional Complications (perforations, tamponade, no reflow, dissections, etc)

Interventional Pharmacology: Antiarrhythmics

Interventional Pharmacology: Inotropes and Vasopressors

Interventional Pharmacology: Procedural Sedation

Interventional Pharmacology—Vasodilators

Intravascular Ultrasound

Ivabradine

LCZ696

Left Atrial Intervention

Left Main Intervention

Long QT Syndromes and Torsade de Pointes

Magnetic Resonance Imaging

Management of Hypertension

Management of Pulmonary Hypertension

Managing the Patient with a Ventricular Assist Device

Mechanical Support

Mitral Regurgitation

Mitral Regurgitation

Mitral Regurgitation: Transcatheter Repair

Mitral Stenosis: Percutaneous Transvenous Mitral Commissurotomy

Modes of cardiac pacing: Nomenclature, Selection and Indications for permanent cardiac pacing

NSAIDS and CAD: Risks vs. Benefits

Noninvasive Risk Stratification: How Does a Clinician Decide Test Selection and Appropriateness

Optical Coherence Tomography

Other Imaging Modalities

Other Mechanical Circulatory Support Systems

Outcomes and Management of Women with Microvascular Angina and Microvascular Coronary Dysfunction

PCI for STEMI

PCI for Stable CAD

PCI of UA/USTEMI

PCI, CABG Surgery and Medical Therapy in the Diabetic Patient

Patent Foramen Ovale/Atrial Septal Defect/Ventricular Septal Defect Closure

Peri-partum Cardiomyopathy

Pericardial Intervention

Peripheral Interventions

Practical Approach to Managing Dyslipidemia: Role of Statins

Preventing Heart Failure

Radial Access and Intervention

Ranolazine, Ivabradine, and Newer Anti-Anginal Agents

Recognition and Management of the Patient with Stage B Heart Failure

Recognizing and Treating Rejection

Renal Artery Intervention (including renal denervation)

Revascularization

Risk Stratification of the ACS Patient in the Emergency Department and Initial Medical Therapy

Role of PCI and Catheter-Based Revascularization for Symptomatic Stable Ischemic Heart Disease (including Role of Fractional Flow Reserve)

Role of Standard Treadmill Exercise Testing in CAD Diagnosis and risk stratification

Role of Stress Echocardiography to Diagnose CAD: When and In Whom?

Rotational Atherectomy

Saphenous Vein Graft Intervention

Screening and Treating Transplant Coronary Artery Disease

Secondary (Functional) Mitral Regurgitation

Selecting PCI, CABG or medical therapy: Current Recommendations

Selection of Patients for Cardiac Transplantation

Sleep Disordered Breathing

Stent Thrombosis

Telemonitoring

The 6 Minute Walk Test

The Emerging Role of Cardiac CT and Calcium Scoring in the Diagnosis of CAD

Transition from Inpatient to Outpatient

Treating Heart Failure with Preserved Ejection Fraction

Treatment of Acute Heart Failure

Treatment of Ventricular Arrhythmias

Ultrasound Guided Femoral Access in Peripheral Interventions

Use of the Echocardiogram to Define the Presence, Extent, and Etiology of Cardiac Dysfunction

Using Biomarkers to Follow Heart Failure Patients

Valvular Prostheses

Vascular Closure Devices

Vasodilator Drugs: Chronic Vasodilator Therapy – Hydralazine

Vasodilator Drugs: Chronic Vasodilator Therapy – Hydralazine Nitrate Combination

Vasodilator Drugs: Chronic Vasodilator Therapy – Nitrates

Vasodilator Drugs: Chronic Vasodilator Therapy – Other Vasodilators

Vasodilator Drugs: Acute Vasodilator Intervention – Nitroglycerin

Vasodilator Drugs: Acute Vasodilator Intervention – Nitroprusside

Vasodilator Drugs; Acute Vasodilator Intervention – Nesiritide

Ventricular Assist Devices as Bridges or Destination Therapy

Ventricular Tachycardia with No Structural Heart Disease: Recognition and Treatment

When and in Whom Should Stress Myocardial Perfusion Imaging be Performed

Which CAD patient should be referred for cardiac rehabilitation?

Wolff Parkinson White Syndrome: Diagnosis and Treatment

Next post in Cardiology

Cardiopulmonary Exercise Testing